Investors

SEC Filings

SEC Filings

Filing date	Form	Description	View
September 25, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-253955.pdf 0001193125-20-253955.rtf 0001193125-20-253955.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
September 25, 2020	CT ORDER	CT ORDER	View HTML
September 11, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-244225.pdf 0001193125-20-244225.rtf 0001193125-20-244225.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
September 3, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-239118.pdf 0001193125-20-239118.rtf 0001193125-20-239118.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 10, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-214901.pdf 0001193125-20-214901.rtf 0001193125-20-214901.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
August 10, 2020	10-Q	Quarterly report which provides a continuing view of a company's financial position	0001628280-20-012337.pdf 0001628280-20-012337.rtf 0001628280-20-012337.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
July 15, 2020	CT ORDER	CT ORDER	View HTML
July 2, 2020	4	Statement of changes in beneficial ownership of securities	0000899243-20-018268.pdf 0000899243-20-018268.rtf 0000899243-20-018268.xls View HTML
July 2, 2020	3	Initial filing by director officer or owner of more than ten percent.	0000899243-20-018265.pdf 0000899243-20-018265.rtf 0000899243-20-018265.xls View HTML
June 18, 2020	8-K	Report of unscheduled material events or corporate event	0001193125-20-172476.pdf 0001193125-20-172476.rtf 0001193125-20-172476.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Data provided by Kaleidoscope.

Print Page

Email Page

Contact IR

Email Alerts

Tear Sheet

Akebia Therapeutics, Inc.
245 First Street, Suite 1400
Cambridge, MA 02142

Driving Directions

+1 617.871.2098 phone
+1 617.871.2099 fax